search
Back to results

Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation (PREVENTION)

Primary Purpose

Critical Illness, Respiratory Failure

Status
Not yet recruiting
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Noradrenaline
Sponsored by
University of Turin, Italy
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Critical Illness focused on measuring tracheal intubation

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient is admitted or scheduled for admission to a participating study hospital
  • Planned procedure is tracheal intubation and planned operator is a provider expected to routinely perform endotracheal intubation in the participating unit
  • Critical illness (i.e. life-threatening condition with intubation required for cardiorespiratory failure or neurological impairment)
  • Administration of sedation (with or without neuromuscular blockade) is planned
  • Age 18 years or older

Exclusion Criteria:

  • Operator feels vasopressor support is absolutely indicated or contraindicated in the patient
  • Urgency of intubation precludes safe performance of study procedures
  • Intubation performed during cardiopulmonary resuscitation of a patient in cardiac arrest
  • Pregnant or suspected pregnancy

Sites / Locations

  • CHU de Nantes
  • Galway University Hospitals
  • University Hospital San Luigi Gonzaga

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Pre-emptive vasopressor

No vasopressor

Arm Description

Pre-emptive continuous infusion of norepinephrine during intubation

No pre-emptive administration of vasopressors

Outcomes

Primary Outcome Measures

Number of patients with cardiovascular collapse
Composite outcome of mean arterial pressure < 60 mmHg or cardiac arrest

Secondary Outcome Measures

Number of patients with cardiac arrest
Development of either a shockable or non shockable rhythm associated with cardiac arrest
Number of patients with MAP < 60 mmHg
Mean arterial pressure < 60 mmHg
Need for a rescue vasopressor
Any unplanned administration of a vasopressor (either as bolus or continuous infusion)
Change in SBP value from last value before induction to lowest value
Drop of the systolic blood pressure from baseline value to the lowest value registered by 30 minutes from induction
Lowest value of SBP
Lowest systolic blood pressure
Number of patients with severe hypertension
Mean arterial pressure > 120 mmHg

Full Information

First Posted
August 10, 2021
Last Updated
February 22, 2023
Sponsor
University of Turin, Italy
Collaborators
Istituto Di Ricerche Farmacologiche Mario Negri
search

1. Study Identification

Unique Protocol Identification Number
NCT05014581
Brief Title
Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation
Acronym
PREVENTION
Official Title
Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation. The PREVENTION Randomized Multicenter Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
April 2023 (Anticipated)
Primary Completion Date
November 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Turin, Italy
Collaborators
Istituto Di Ricerche Farmacologiche Mario Negri

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Tracheal intubation (TI) is associated with a high risk of adverse events in critically ill patients and peri-intubation hemodynamic collapse is the most commonly observed. The primary aim of the PREVENTION trial is to compare the effect of the pre-emptive use of noradrenaline versus no peri-intubation use of noradrenaline on incidence of cardiovascular collapse following TI in adult critically ill patients. Patients with absolute indication or contraindication to vasopressor support will be excluded from this trial. Patients will be randomized 1:1 to a continuous infusion of noradrenaline started before induction titrated according to baseline mean arterial pressure. The primary outcome will be the incidence of cardiovascular collapse. Secondary outcomes will include lowest systolic blood pressure and cardiac arrest within 30 minutes from intubation.
Detailed Description
PREVENTION trial is a pragmatic, multi-center, un-blinded, parallel group, randomized study comparing the pre-emptive use of noradrenaline to no-vasopressors during the peri-intubation period of adult critically ill patients. Investigators hypothesize that the pre-emptive administration of noradrenaline would mitigate the incidence and severity of peri-intubation cardiovascular collapse. The study will include adult (18 yrs or older) critically ill patients needing in-hospital intubation, excluding patients with absolute indication or contraindication to vasopressors. Patients will be randomized to receive either a continuous infusion of noradrenaline started at least 8 minutes before induction vs no vasopressors during the peri-intubation period. All co-interventions will be provided according to clinician's judgement. The primary outcome of the study will be a composite of MAP < 60 mmHg or cardiac arrest. Secondary outcomes will include lowest systolic blood pressure < 30 minutes from induction, change in systolic blood pressure from baseline to the lowest value within 30 minutes from induction and cardiac arrest.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness, Respiratory Failure
Keywords
tracheal intubation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
420 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Pre-emptive vasopressor
Arm Type
Experimental
Arm Description
Pre-emptive continuous infusion of norepinephrine during intubation
Arm Title
No vasopressor
Arm Type
No Intervention
Arm Description
No pre-emptive administration of vasopressors
Intervention Type
Drug
Intervention Name(s)
Noradrenaline
Other Intervention Name(s)
Norepinephrine
Intervention Description
Pre-emptive continuous infusion of noradrenaline during the peri-intubation period
Primary Outcome Measure Information:
Title
Number of patients with cardiovascular collapse
Description
Composite outcome of mean arterial pressure < 60 mmHg or cardiac arrest
Time Frame
30 minutes from induction
Secondary Outcome Measure Information:
Title
Number of patients with cardiac arrest
Description
Development of either a shockable or non shockable rhythm associated with cardiac arrest
Time Frame
30 minutes from induction
Title
Number of patients with MAP < 60 mmHg
Description
Mean arterial pressure < 60 mmHg
Time Frame
30 minutes from induction
Title
Need for a rescue vasopressor
Description
Any unplanned administration of a vasopressor (either as bolus or continuous infusion)
Time Frame
30 minutes from induction
Title
Change in SBP value from last value before induction to lowest value
Description
Drop of the systolic blood pressure from baseline value to the lowest value registered by 30 minutes from induction
Time Frame
30 minutes from induction
Title
Lowest value of SBP
Description
Lowest systolic blood pressure
Time Frame
30 minutes from induction
Title
Number of patients with severe hypertension
Description
Mean arterial pressure > 120 mmHg
Time Frame
30 minutes from induction
Other Pre-specified Outcome Measures:
Title
Number of patients with cardiac arrhythmias
Description
Any ventricular or supraventricular arrhythmia
Time Frame
30 minutes from induction
Title
Number of patients with bradycardia
Description
Heart rate < 60 beats per minute
Time Frame
30 minutes from induction
Title
Signs of tissue/peripheral ischemia at noradrenaline infusion site
Description
Any sign of tissue/limb ischemia in case of peripheral vein infusion of noradrenaline
Time Frame
24 hours
Title
Need for new start of renal replacement therapy
Description
Need to start either continuous or intermittent renal replacement therapy
Time Frame
28 days from intubation
Title
Total amount of fluid administered (ml)
Description
Cumulative volume of fluids (ml)
Time Frame
30 minutes from induction
Title
First pass intubation success
Description
Confirmed intubation after a single attempt of laryngoscopy
Time Frame
30 minutes from induction
Title
Total amount of rescue vasopressors after induction
Description
Cumulative dose of any vasopressor administered either as a bolus or continuous infusion
Time Frame
30 minutes from induction
Title
ICU-free days
Description
Total number of days outside the ICU up to 28 days
Time Frame
28 days from intubation
Title
Ventilator-free days
Description
Total number of days free from invasive mechanical ventilation
Time Frame
28 days from intubation
Title
Vasopressor-free days
Description
Total number of days free from any vasopressor administration
Time Frame
28 days from intubation
Title
In-hospital mortality
Description
Death during the hospital admission up to 28 days
Time Frame
28 days from intubation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient is admitted or scheduled for admission to a participating study hospital Planned procedure is tracheal intubation and planned operator is a provider expected to routinely perform endotracheal intubation in the participating unit Critical illness (i.e. life-threatening condition with intubation required for cardiorespiratory failure or neurological impairment) Administration of sedation (with or without neuromuscular blockade) is planned Age 18 years or older Exclusion Criteria: No vasopressors/inotropes at the moment of screening for eligibility MAP < 60 mmHg or > 120 mmHg at the moment of screening for eligibility Urgency of intubation precludes safe performance of study procedures Intubation performed during cardiopulmonary resuscitation of a patient in cardiac arrest Enrolled in another clinical trial that is unapproved for co-enrollment Pregnant or suspected pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Vincenzo Russotto, MD
Phone
+393297893044
Email
vincenzo.russotto@unito.it
First Name & Middle Initial & Last Name or Official Title & Degree
Antonella Vasamì
Email
antonella.vasami@marionegri.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vincenzo Russotto, MD
Organizational Affiliation
University Hospital San Luigi Gonzaga
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
John G Laffey, MD
Organizational Affiliation
University Hospital Galway, NUI Galway, Ireland
Official's Role
Study Chair
Facility Information:
Facility Name
CHU de Nantes
City
Nantes
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean Baptiste Lascarrou, MD, PhD
Facility Name
Galway University Hospitals
City
Galway
Country
Ireland
Facility Contact:
First Name & Middle Initial & Last Name & Degree
John G Laffey, MD
Facility Name
University Hospital San Luigi Gonzaga
City
Orbassano
State/Province
Turin
ZIP/Postal Code
10043
Country
Italy
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vincenzo Russotto, MD
Email
vincenzo.russotto@unito.it
First Name & Middle Initial & Last Name & Degree
Pietro Caironi, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
33755076
Citation
Russotto V, Myatra SN, Laffey JG, Tassistro E, Antolini L, Bauer P, Lascarrou JB, Szuldrzynski K, Camporota L, Pelosi P, Sorbello M, Higgs A, Greif R, Putensen C, Agvald-Ohman C, Chalkias A, Bokums K, Brewster D, Rossi E, Fumagalli R, Pesenti A, Foti G, Bellani G; INTUBE Study Investigators. Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries. JAMA. 2021 Mar 23;325(12):1164-1172. doi: 10.1001/jama.2021.1727. Erratum In: JAMA. 2021 May 24;:null.
Results Reference
result
PubMed Identifier
31529354
Citation
Russotto V, Myatra SN, Laffey JG. What's new in airway management of the critically ill. Intensive Care Med. 2019 Nov;45(11):1615-1618. doi: 10.1007/s00134-019-05757-0. Epub 2019 Sep 16. No abstract available.
Results Reference
result
PubMed Identifier
31585796
Citation
Janz DR, Casey JD, Semler MW, Russell DW, Dargin J, Vonderhaar DJ, Dischert KM, West JR, Stempek S, Wozniak J, Caputo N, Heideman BE, Zouk AN, Gulati S, Stigler WS, Bentov I, Joffe AM, Rice TW; PrePARE Investigators; Pragmatic Critical Care Research Group. Effect of a fluid bolus on cardiovascular collapse among critically ill adults undergoing tracheal intubation (PrePARE): a randomised controlled trial. Lancet Respir Med. 2019 Dec;7(12):1039-1047. doi: 10.1016/S2213-2600(19)30246-2. Epub 2019 Oct 1.
Results Reference
result

Learn more about this trial

Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation

We'll reach out to this number within 24 hrs